Wednesday, October 1, 2025
  • Login
Forbes 40under40
  • Home
  • Technology
  • Innovation
  • Real Estate
  • Leadership
  • Money
  • Lifestyle
No Result
View All Result
  • Home
  • Technology
  • Innovation
  • Real Estate
  • Leadership
  • Money
  • Lifestyle
No Result
View All Result
Forbes 40under40
No Result
View All Result
Home Lifestyle

Abbott beats quarterly profit estimates on strong medical device sales

by Riah Marton
in Lifestyle
Abbott beats quarterly profit estimates on strong medical device sales
Share on FacebookShare on Twitter


ABBOTT Laboratories beat Wall Street estimates for quarterly profit on Wednesday (Apr 17) and raised the lower end of its forecast, as robust demand for medical procedures boosted sales of its devices, including its glucose-monitoring products.

Sales of Abbott’s medical devices have been strengthened in recent quarters due to a resurgence in the demand for joint replacements as well as other surgeries that were delayed during the Covid-19 pandemic.

The company recorded medical device sales of US$4.45 billion, of which its glucose monitor, FreeStyle Libre, generated US$1.5 billion. Analysts, on average, had estimated Abbott’s medical device sales at US$4.30 billion, according to LSEG data.

The company recorded US$9.96 billion in sales, compared to analysts’ estimate of US$9.88 billion.

On an adjusted basis, it reported first-quarter profit of 98 cents per share, compared with analysts’ estimate of 95 cents per share, according to LSEG data.

The company now expects a full-year profit of US$4.55 to US$4.70 per share, raising the lower end from US$4.50 per share. Analysts were expecting a profit of US$4.60 per share. REUTERS

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

Tags: AbbottBeatsDeviceEstimatesMedicalProfitQuarterlySalesStrong
Riah Marton

Riah Marton

I'm Riah Marton, a dynamic journalist for Forbes40under40. I specialize in profiling emerging leaders and innovators, bringing their stories to life with compelling storytelling and keen analysis. I am dedicated to spotlighting tomorrow's influential figures.

Next Post
Carol Baum: Hollywood Producer Slams Sydney Sweeney Calling Her Movie ‘Anyone But You’ ‘Unwatchable’ and Says She ‘Isn’t Pretty’ And ‘Can’t Act’

Carol Baum: Hollywood Producer Slams Sydney Sweeney Calling Her Movie 'Anyone But You' 'Unwatchable' and Says She 'Isn't Pretty' And 'Can't Act'

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.

 
 
 
 

NEWS

  • Forbes Magazine
  • Technology
  • Innovation
  • Money
  • Leadership
  • Real Estate
  • Lifestyle
Instagram Facebook Youtube

© 2025 Forbes 40under40. All Rights Reserved.

  • About Us
  • Advertise
  • Contact Us
No Result
View All Result
  • Home
  • Technology
  • Innovation
  • Real Estate
  • Leadership
  • Money
  • Lifestyle

© 2024 Forbes 40under40. All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In